I would like to purchase a multi-tumor marker pathology diagnostic chip. What models are available from stock and what are the quotations?

When selecting, don't just focus on in-stock models. Key checks include the tissue microarray map, donor pathology information, whether colorectal cancer and normal controls are included, and whether supplier validation data exist for all four markers. Once the in-stock product is received, first perform HE and single-plex IHC validation to confirm tissue morphology, array integrity, and absence of tissue detachment; do not proceed directly to multiplex staining in the first round, otherwise it will be difficult to determine whether problems arise from the microarray or the staining system. You may request the electronic version of the array map and previous staining images from the supplier, and prioritize slides with moderate array density and anti-detachment treatment.

Pricing and volume discounts mainly depend on the number of core spots, replicate spot design, whether normal/tumor paired controls are included, and whether IHC QC data have been generated. It is advisable not to ask only for a single-slide quote; instead, require the supplier to break down the quotation into: base chip price, price per section, additional QC staining, and cold-chain shipping. For bulk procurement, you can negotiate tiered discounts. For 200 cases, it is usually possible to negotiate a lower price than for single slides, but the specific percentage depends on the manufacturer's policy. Trial samples are not necessarily free; more often, you purchase 1-2 test slides. If you subsequently increase the order volume, you can request that the trial purchase cost be credited toward the bulk order, or that sections from the same batch be supplied as a supplement.

For supplier comparison, it is recommended to look at four dimensions: first, spot inventory and patch policies—clarify whether subsequent repeat purchases can maintain the same batch number or provide supplementary patches from the same source; second, whether pathological quality control and ethical documents are complete, especially the declaration of clinical sample sources; third, whether the delivery time and cold chain records are traceable; fourth, the response speed of domestic agents versus imported original manufacturers—import customs clearance may add 1–2 weeks. For bulk procurement, you can request reserved section services to avoid re-embedding all samples when additional samples are needed later. Overall, do not ignore later patch and validation costs for a low per-slide price.

Regarding in-stock models and lead times, it is recommended to directly request colorectal cancer-related catalogs from suppliers specializing in tissue microarrays and pathology quality control, focusing on screening panels that simultaneously contain CK, CDX2, MLH1, and p53. If a single slide cannot cover these markers, consider using a combination of two slides from the same batch to avoid batch-to-batch variability. Common spot diameters for in-stock products are 0.6/1.0/1.5 mm. For 200 cases, it is advisable to choose a model that includes replicate cores and normal controls to reduce sampling error. Many manufacturers support purchasing 1-2 individual slides first for validation. Lead times for in-stock items are generally short, but are subject to actual inventory. Before placing an order, have the sales representative confirm inventory status and cold-chain shipping time.